ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
July 21, 2022 18:00 ET
|
ProPhase Labs, Inc.
Garden City, NY, July 21, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified diagnostics and genomics company, today announced that it has granted an inducement stock option...
ProPhase Labs to Host Live Webcast to Discuss Business Developments on Thursday, July 21, 2022
July 19, 2022 08:30 ET
|
ProPhase Labs, Inc.
Garden City, NY, July 19, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified diagnostics and genomics company, today announced that it will host a live webcast on Thursday,...
ProPhase Labs to Present at the Spring Into Action – Best Ideas Virtual Investor Conference
May 11, 2022 18:25 ET
|
ProPhase Labs, Inc.
Garden City, NY, May 11, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified diagnostics and genomics company, today announced that Chairman and CEO Ted Karkus will present at...
ProPhase Labs to Host First Quarter 2022 Financial Results Conference Call on Friday, May 13, 2022 at 11:00 a.m. Eastern Time
May 06, 2022 16:30 ET
|
ProPhase Labs, Inc.
GARDEN CITY, NY, May 06, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified diagnostics and genomics company, will hold a conference call on Friday, May 13, 2022 at 11:00...
ProPhase Labs Announces Record Financial Results for the Fourth Quarter and Full Year Ended December 31, 2021
March 30, 2022 08:30 ET
|
ProPhase Labs, Inc.
Record Financial Results also expected for Q1 2022 Company to hold a conference call March 30, 2022, at 11:00AM ET Garden City, NY, March 30, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs,...